Epidemiological impact of tenofovir gel on the HIV epidemic in South Africa

Journal of Acquired Immune Deficiency Syndromes

Volumn 58, Issue 2, 2011, Pages 207-210

  Williams, Brian G ^a   Abdool Karim, Salim S ^b   Karim, Quarraisha Abdool ^b   Gouws, Eleanor ^c  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c UNAIDS   (Switzerland)

Author keywords

cost effectiveness; HIV prevention; microbicide gel; South Africa; tenofovir

Indexed keywords

MICROBICIDE; TENOFOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; COST EFFECTIVENESS ANALYSIS; DISABILITY; EPIDEMIC; FEMALE; GEL; HEALTH CARE COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; SEXUAL INTERCOURSE; SOUTH AFRICA; VIRUS TRANSMISSION;

ADENINE; ANTI-HIV AGENTS; COST-BENEFIT ANALYSIS; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MODELS, BIOLOGICAL; PHOSPHONIC ACIDS; PREVALENCE; SOUTH AFRICA; VAGINAL CREAMS, FOAMS, AND JELLIES;

EID: 80052962337     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182253c19     Document Type: Article

References (18)

1. Gouws E, for The International Group on Analysis of Trends in HIV Prevalence and Behaviours in Young People in Countries most Affected by HIV. Trends in HIV prevalence and sexual behaviour among young people aged 15-24 years in countries most affected by HIV. Sex Transm Infect. 2010;86(suppl 2):ii72-ii83.
2. UNAIDS. Report on the Global AIDS Epidemic. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS; 2008.
3. White RG, Orroth KK, Glynn JR, et al. Treating curable sexually transmitted infections to prevent HIV in Africa: still an effective control strategy? J Acquir Immune Defic Syndr. 2008;47:346-353. (Pubitemid 351619422)
4. Ross DA, Changalucha J, Obasi AI, et al. Biological and behavioural impact of an adolescent sexual health intervention in Tanzania: a community-randomized trial. AIDS. 2007;21:1943-1955. (Pubitemid 47329771)
5. Lissouba P, Taljaard D, Rech D, et al. A model for the roll-out of comprehensive adult male circumcision services in African low-income settings of high HIV incidence: the ANRS 12126 Bophelo Pele Project. PLoS Med. 2010;7:e1000309.
6. Hallett TB, Alsallaq RA, Baeten JM, et al.Will circumcision provide even more protection from HIV to women and men? New estimates of the population impact of circumcision interventions. Sex Transm Infect. 2011; 87:88-93.
7. Foss AM, Watts CH, Vickerman P, et al. Condoms and prevention of HIV. Br Med J. 2004;329:185-186. (Pubitemid 39013273)
8. Egger M. Outcomes of ART in resource-limited and industrialized countries. Paper presented at: 14th Conference on Retriviruses and Opportunistic Infections; Februray 25-28, 2007; San Francisco, CA.
9. Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2011;329:1168-1174.
10. Abdool Karim SS, Churchyard GJ, Abdool Karim Q, et al. HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. Lancet. 2009;374:921-933.
11. Gouws E, Stanecki KA, Lyerla R, et al. The epidemiology of HIV infection among young people aged 15-24 years in southern Africa. AIDS. 2008;22(suppl 4):S5-S16.
12. Williams BG, Lloyd-Smith JO, Gouws E, et al. The potential impact of male circumcision on HIV in sub-Saharan Africa. PLoS Med. 2006;3(7).
13. Anderson RM, May RM. Infectious Diseases of Humans: Dynamics and Control. Oxford, United Kingdom: Oxford University Press; 1991.
14. Verguet S, Walsh JA. Vaginal microbicides save money: a model of costeffectiveness in South Africa and the USA. Sex Transm Infect. 2010;86: 212-216.
15. Sachs J. Report of the Commission on Macroeconomics and Health. Geneva, Switzerland: World Health Organization; December 2001.
16. Farivari R, Chandrasekaran R, Chi Y, et al. World Development Indicators Database, Revised 9 July 2010. Washington, DC World Bank; 2010. Available at: http://siteresources.worldbank.org/DATASTATISTICS/Resources/GNIPC.pdf. Accessed September 13, 2010.
17. Bertozzi S, Padian NS, Wegbreit J, et al. HIV/AIDS prevention and treatment. In: Jamison DT, ed. Disease Control Priorities in Developing Countries. Washington, DC; Oxford University Press and the World Bank; 2006.
18. Gouws E, Williams BG, Sheppard HW, et al. High incidence of HIV-1 in South Africa using a standardized algorithm for recent HIV seroconversion. J Acquir Immune Defic Syndr. 2002;29:531-535. (Pubitemid 34456346)